Viewing Study NCT00513851

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-01-27 @ 4:41 AM
Study NCT ID: NCT00513851
Status: COMPLETED
Last Update Posted: 2011-09-27
First Post: 2007-08-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 1 Study of OSI-930 in Cancer Patients
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Cancer View
None Non-small cell lung cancer View
None Small cell lung cancer View
None Uterine cancer View
None Ovarian cancer View
None Renal cancer View
None Head and neck cancer View
None Cervical cancer View
None Metastatic cancer View
None Colorectal cancer View
None Gastrointestinal stromal tumors View